Macrophages Orchestrate the Liver Tumor Microenvironment

Area of Science:

• Oncology
• Immunology
• Hepatology

Background:

• Liver cancer, including hepatocellular carcinoma and cholangiocarcinoma, has poor therapeutic options and high mortality.
• The tumor microenvironment (TME) is crucial for liver cancer progression.
• Tumor-associated macrophages (TAMs) are key immune cells in the liver TME, promoting cancer growth and indicating poor prognosis.

Purpose of the Study:

• To review recent advances in understanding TAM heterogeneity and function in liver cancer.
• To highlight TAMs' role in modulating the liver tumor microenvironment (TME).
• To discuss targeting macrophage subpopulations as a therapeutic strategy for liver cancer.

Main Methods:

• Literature review of recent research on TAMs in liver cancer.
• Analysis of TAM heterogeneity and functional roles within the TME.
• Examination of current clinical trials targeting macrophages for liver cancer.

Main Results:

• TAMs are abundant in liver tumors and significantly influence cancer progression.
• TAMs promote immunosuppression, desmoplasia, and angiogenesis within the TME.
• Targeting specific TAM subpopulations is a promising therapeutic avenue.

Conclusions:

• Understanding TAM heterogeneity is vital for developing effective liver cancer therapies.
• Modulating TAMs within the TME offers a novel strategy to improve treatment outcomes.
• Clinical trials targeting macrophages show potential for treating liver cancer.